CS
AMPE

Credit Suisse’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Credit Suisse’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 4253
2022
Q3 		– Hold
0
– – – 4506
2022
Q2 		– Hold
0
– – – 4575
2021
Q2 		– Sell
-59
Closed -$30K – 4706
2021
Q1 		$30K Buy
+59
New +$30.4K ﹤0.01% 4249
2019
Q3 		– Sell
-92
Closed -$11K – 4316
2019
Q2 		$11K Buy
92
+15
+19% +$2.38K ﹤0.01% 4057
2019
Q1 		$13K Buy
77
+22
+40% +$3.77K ﹤0.01% 3952
2018
Q4 		$7K Buy
+55
New +$8.44K ﹤0.01% 3854
2018
Q3 		– Sell
-77
Closed -$51K – 4063
2018
Q2 		$51K Buy
+77
New +$57.6K ﹤0.01% 3904
2017
Q1 		– Sell
-63
Closed -$17K – 4153
2016
Q4 		$17K Sell
63
-19
-23% -$4.53K ﹤0.01% 4065
2016
Q3 		$18K Sell
82
-10
-11% -$2.8K ﹤0.01% 4057
2016
Q2 		$36K Sell
92
-109
-54% -$119K ﹤0.01% 4167
2016
Q1 		$136K Buy
201
+92
+84% +$62K ﹤0.01% 3776
2015
Q4 		$115K Buy
+109
New +$108K ﹤0.01% 4057
2015
Q3 		– Sell
-179
Closed -$127K – 4555
2015
Q2 		$127K Buy
+179
New +$191K ﹤0.01% 4347
2015
Q1 		– Sell
-265
Closed -$273K – 4641
2014
Q4 		$273K Sell
265
-256
-49% -$274K ﹤0.01% 4113
2014
Q3 		$552K Buy
521
+275
+112% +$463K ﹤0.01% 3569
2014
Q2 		$617K Sell
246
-324
-57% -$661K ﹤0.01% 3682
2014
Q1 		$1.09M Buy
570
+469
+464% +$1.11M ﹤0.01% 3046
2013
Q4 		$216K Buy
101
+28
+38% +$66.2K ﹤0.01% 4286
2013
Q3 		$165K Buy
73
+27
+59% +$52.2K ﹤0.01% 4020
2013
Q2 		$79K Buy
+46
New +$73K ﹤0.01% 4058

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Credit Suisse's AMPE Position: Q4 2022 in Review

Credit Suisse held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4253.

Credit Suisse first reported a position in AMPE in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.09M in Q1 2014. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Credit Suisse held 0 shares of Ampio Pharmaceuticals Inc. worth $0 as of Q4 2022.
  • Credit Suisse left its Ampio Pharmaceuticals Inc. share count unchanged in Q4 2022.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of Credit Suisse's portfolio in Q4 2022, its #4253 holding.
  • Credit Suisse first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and has held it in 18 quarters since.
  • Credit Suisse's Ampio Pharmaceuticals Inc. position peaked at $1.09M in Q1 2014.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.